For expert advice contact us:

tel: 0141 333 6750

Request a callback
  1. Your name(*)
    Please let us know your name.
  2. Your phone number(*)
    Please let us know your phone number.
  3. Anti - Spam Verification
    Anti - Spam Verification Invalid Input
  4. Invalid Input

Blog Latest

Dallas McMillan Glasgow Solicitors

A leading corporate and commercial law practice based in Glasgow, Scotland, Dallas McMillan delivers high quality legal services to clients across the United Kingdom and beyond with its international capabilities.

Contact us today on 0141 333 6750.

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Login
Posted by on in Personal Injury Claims
  • Font size: Larger Smaller
  • Hits: 1125
  • 0 Comments

Review into PiP implant scandal published

A review into the PiP breast implant scandal has found that, although the regulator acted appropriately and followed scientific and clinical advice, there is room for improvement and serious lessons must be learned.

Health Minister Lord Howe’s report into PiP breast implants has looked at whether the UK regulator – the MHRA – and the Department of Health acted appropriately both before and after information about the problems with these implants came to light.

The report states that the MHRA and the Department of Health must learn lessons so that they can continue to improve their approach to communicating with affected individuals and the general public, particularly around issues that cause such understandable anxiety. They must ensure that full, clear and accurate information is made available promptly in a way that is easily accessible and reflects the concerns that weigh so heavily on the lives of patients who are affected by doubts over the safety of specific medical devices.

The role of the MHRA is to monitor all incidents that are reported to it, make sure that these incidents are investigated fully and that any necessary action is taken. The evidence shows that the regulator did this but that improvements are needed in its communication and data collection and the whole European system and processes for gathering and analysing data where concerns arise.

Lessons need to be learnt by the MHRA, the Department of Health and the wider system so it can uncover problems early, be better placed to take robust action and provide clarity for the public should anything like this happen in the future.

A leading corporate and commercial law practice based in Glasgow, Scotland, we deliver high quality legal services to clients across the United Kingdom and beyond with our international capabilities. Contact us today on 0141 333 6750.

Comments